Sepracor, King to slash sales forces

Share this article:
Small pharma is taking a cue from its Big Pharma brethren as it trims its sales force size to improve market position.

In late October, Sepracor announced the elimination of 300 sales force positions as part of a cost cutting plan to reduce expenses by $90 million-$100 million for 2008.

Meanwhile, King Pharmaceuticals will cut 20% of its 2,600 employee workforce after a federal appeals court judge ruled against a patent extension on its blood pressure treatment Altace. Most of the 520 layoffs will come from the firm's field sales force. King anticipates it will save $75 million-$90 million in 2008 as a result of the cuts.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?